Home » Topics » Regulatory » Patents

Patents
RSS

Klotho Therapeutics synthesizes novel compounds for hypertension

Feb. 7, 2022

VelosBio identifies new anti-ROR1 ADCs

Feb. 7, 2022

Aligos Therapeutics discloses new THR agonists

Feb. 7, 2022

Tactogen patents 5-HT1B receptor agonists and MAO-A inhibitors

Feb. 7, 2022

BioWorld MedTech Patent Highlights: Week 4

From Current Patent Gazette

Feb. 4, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New plasma kallikrein inhibitors identified at Merck Sharp & Dohme

Feb. 4, 2022

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

Feb. 4, 2022

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Feb. 4, 2022

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Feb. 4, 2022

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

Feb. 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...